The functional impact of heterozygous deletion of NRXN1 has been investigated in human-derived isogenic embryonic stem cells (ESC) and iPSCs from individuals with schizophrenia and autism (Pak et al., 2015, 2021; Avazzadeh et al., 2019, 2021). Here, NRXN1 is linked to schizophrenia.